Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 100.00 / 2.21M |
Day Range | - - - |
52 Wk Range | 3.79 - 15.70 |
Market Cap | $651.74M |
P/E Ratio | 51.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 16.48% |
Days to Cover | 8.38 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL) and Opthea (NASDAQ:OPT).
Ironwood Pharmaceuticals has a consensus price target of $13.86.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $4.08 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.